Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 546

1.

Cre recombinase toxicity in podocytes: a novel genetic model for FSGS in adolescent mice.

Frahsek M, Schulte K, Chia-Gil A, Djudjaj S, Schueler H, Leuchtle K, Smeets B, Dijkman H, Floege J, Moeller MJ.

Am J Physiol Renal Physiol. 2019 Nov 1;317(5):F1375-F1382. doi: 10.1152/ajprenal.00573.2018. Epub 2019 Oct 7.

PMID:
31588799
2.

A new tool to predict the risk of progression in IgA nephropathy.

Floege J.

Kidney Int. 2019 Oct;96(4):808-809. doi: 10.1016/j.kint.2019.07.009. Epub 2019 Aug 1. No abstract available.

PMID:
31471162
3.

Speckle Tracking Echocardiography and All-Cause and Cardiovascular Mortality Risk in Chronic Kidney Disease Patients.

Jahn L, Kramann R, Marx N, Floege J, Becker M, Schlieper G.

Kidney Blood Press Res. 2019;44(4):690-703. doi: 10.1159/000501225. Epub 2019 Aug 15.

4.

A Novel Role for GATA3 in Mesangial Cells in Glomerular Development and Injury.

Grigorieva IV, Oszwald A, Grigorieva EF, Schachner H, Neudert B, Ostendorf T, Floege J, Lindenmeyer MT, Cohen CD, Panzer U, Aigner C, Schmidt A, Grosveld F, Thakker RV, Rees AJ, Kain R.

J Am Soc Nephrol. 2019 Sep;30(9):1641-1658. doi: 10.1681/ASN.2018111143. Epub 2019 Aug 12.

PMID:
31405951
5.

Non-invasive evaluation of coronary heart disease in patients with chronic kidney disease using photoplethysmography.

Saritas T, Greber R, Venema B, Puelles VG, Ernst S, Blazek V, Floege J, Leonhardt S, Schlieper G.

Clin Kidney J. 2019 Jan 25;12(4):538-545. doi: 10.1093/ckj/sfy135. eCollection 2019 Aug.

6.

[Science as a cornerstone of medical education and training].

Floege J, Gamstätter T.

Dtsch Med Wochenschr. 2019 Aug;144(15):1005. doi: 10.1055/a-0870-6560. Epub 2019 Jul 26. German. No abstract available.

PMID:
31350738
7.

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.

Inker LA, Heerspink HJL, Tighiouart H, Levey AS, Coresh J, Gansevoort RT, Simon AL, Ying J, Beck GJ, Wanner C, Floege J, Li PK, Perkovic V, Vonesh EF, Greene T.

J Am Soc Nephrol. 2019 Sep;30(9):1735-1745. doi: 10.1681/ASN.2019010007. Epub 2019 Jul 10.

PMID:
31292197
8.

High-fat diet-induced obesity causes an inflammatory microenvironment in the kidneys of aging Long-Evans rats.

Laurentius T, Raffetseder U, Fellner C, Kob R, Nourbakhsh M, Floege J, Bertsch T, Bollheimer LC, Ostendorf T.

J Inflamm (Lond). 2019 Jun 25;16:14. doi: 10.1186/s12950-019-0219-x. eCollection 2019.

9.

Evaluation of Electrocardiographic Parameters Predicting Cardiovascular Events in Patients with End-Stage Renal Disease before and after Transplantation.

Buerschaper L, Floege J, Mühlfeld A, Schlieper G.

Kidney Blood Press Res. 2019;44(4):615-627. doi: 10.1159/000500917. Epub 2019 Jun 26.

10.

Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium.

Floege J.

J Am Soc Nephrol. 2019 Jul;30(7):1139-1141. doi: 10.1681/ASN.2019040373. Epub 2019 Jun 21. No abstract available.

PMID:
31227635
11.

Novel 3D analysis using optical tissue clearing documents the evolution of murine rapidly progressive glomerulonephritis.

Puelles VG, Fleck D, Ortz L, Papadouri S, Strieder T, Böhner AMC, van der Wolde JW, Vogt M, Saritas T, Kuppe C, Fuss A, Menzel S, Klinkhammer BM, Müller-Newen G, Heymann F, Decker L, Braun F, Kretz O, Huber TB, Susaki EA, Ueda HR, Boor P, Floege J, Kramann R, Kurts C, Bertram JF, Spehr M, Nikolic-Paterson DJ, Moeller MJ.

Kidney Int. 2019 Aug;96(2):505-516. doi: 10.1016/j.kint.2019.02.034. Epub 2019 Mar 15.

12.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Carter SA, Lightstone L, Cattran D, Bagga A, Barbour SJ, Barratt J, Boletis J, Caster D, Coppo R, Fervenza FC, Floege J, Hladunewich M, Hogan JJ, Kitching AR, Lafayette R, Malvar A, Radhakrishnan J, Rovin BH, Zhang H, Gutman T, Howell M, Logeman C, Shen JI, Teixeira-Pinto A, Alexander SI, Cho Y, Craig JC, Harris D, Johnson DW, Kerr PG, Ryan J, Viecelli AK, Wang AY, Wilkie M, Scholes-Robertson N, Tong A; SONG-GD Initiative.

Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047. No abstract available.

PMID:
31122702
13.

Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions.

Kuppe C, Leuchtle K, Wagner A, Kabgani N, Saritas T, Puelles VG, Smeets B, Hakroush S, van der Vlag J, Boor P, Schiffer M, Gröne HJ, Fogo A, Floege J, Moeller MJ.

Kidney Int. 2019 Jul;96(1):80-93. doi: 10.1016/j.kint.2019.01.037. Epub 2019 Feb 27.

14.

Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort.

Lamina C, Kronenberg F, Stenvinkel P, Froissart M, Forer L, Schönherr S, Wheeler DC, Eckardt KU, Floege J.

Nephrol Dial Transplant. 2019 Apr 21. pii: gfz060. doi: 10.1093/ndt/gfz060. [Epub ahead of print]

PMID:
31006013
15.

Antimalarials in IgA Nephropathy: Did Our Supportive Therapy Armamentarium Just Increase?

Floege J.

Am J Kidney Dis. 2019 Jul;74(1):6-8. doi: 10.1053/j.ajkd.2019.02.022. Epub 2019 Apr 18. No abstract available.

PMID:
31005372
16.

Big science and big data in nephrology.

Saez-Rodriguez J, Rinschen MM, Floege J, Kramann R.

Kidney Int. 2019 Jun;95(6):1326-1337. doi: 10.1016/j.kint.2018.11.048. Epub 2019 Mar 5. Review.

17.

Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis.

Sun Q, Baues M, Klinkhammer BM, Ehling J, Djudjaj S, Drude NI, Daniel C, Amann K, Kramann R, Kim H, Saez-Rodriguez J, Weiskirchen R, Onthank DC, Botnar RM, Kiessling F, Floege J, Lammers T, Boor P.

Sci Transl Med. 2019 Apr 3;11(486). pii: eaat4865. doi: 10.1126/scitranslmed.aat4865.

PMID:
30944168
18.

[Immunoglobulin A nephropathy].

Seikrit C, Rauen T, Floege J.

Internist (Berl). 2019 May;60(5):432-439. doi: 10.1007/s00108-019-0588-5. Review. German.

PMID:
30895344
19.

Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis.

Saritas T, Cuevas CA, Ferdaus MZ, Kuppe C, Kramann R, Moeller MJ, Floege J, Singer JD, McCormick JA.

Sci Rep. 2019 Mar 14;9(1):4596. doi: 10.1038/s41598-019-40795-0.

20.

Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.

van Roeyen CRC, Martin IV, Drescher A, Schuett KA, Hermert D, Raffetseder U, Otten S, Buhl EM, Braun GS, Kuppe C, Liehn E, Boor P, Weiskirchen R, Eriksson U, Gross O, Eitner F, Floege J, Ostendorf T.

Kidney Int. 2019 May;95(5):1103-1119. doi: 10.1016/j.kint.2018.11.031. Epub 2019 Feb 28.

PMID:
30827511
21.

Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study.

Schneider MP, Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Friedrich N, Janka R, Uder M, Schmieder RE, Eckardt KU.

Kidney Int Rep. 2018 Oct 11;4(2):267-274. doi: 10.1016/j.ekir.2018.10.004. eCollection 2019 Feb.

22.

Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia.

Kaesler N, Goettsch C, Weis D, Schurgers L, Hellmann B, Floege J, Kramann R.

Nephrol Dial Transplant. 2019 Feb 1. doi: 10.1093/ndt/gfy410. [Epub ahead of print]

PMID:
30715488
23.

[Perspectives 2025 - Positions of the German Society of Internal Medicine].

Vogelmeier C, Floege J, Gamstätter T.

Dtsch Med Wochenschr. 2019 Feb;144(3):207-212. doi: 10.1055/a-0799-5146. Epub 2019 Jan 31. German.

PMID:
30703843
24.

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J; Conference Participants.

Kidney Int. 2019 Feb;95(2):281-295. doi: 10.1016/j.kint.2018.11.008.

25.

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH; Conference Participants.

Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018.

26.

Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.

Thompson A, Carroll K, A Inker L, Floege J, Perkovic V, Boyer-Suavet S, W Major R, I Schimpf J, Barratt J, Cattran DC, S Gillespie B, Kausz A, W Mercer A, Reich HN, H Rovin B, West M, Nachman PH.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):469-481. doi: 10.2215/CJN.08600718. Epub 2019 Jan 11.

PMID:
30635299
27.

Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores).

Schimpf JI, Klein T, Fitzner C, Eitner F, Porubsky S, Hilgers RD, Floege J, Groene HJ, Rauen T.

BMC Nephrol. 2018 Nov 19;19(1):328. doi: 10.1186/s12882-018-1128-6.

28.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
29.

Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.

Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Janka R, Uder M, Schmieder RE, Eckardt KU, Schneider MP.

Hypertension. 2018 Oct;72(4):929-936. doi: 10.1161/HYPERTENSIONAHA.118.11608.

PMID:
30354716
30.

Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.

Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH.

Kidney Blood Press Res. 2018;43(5):1563-1572. doi: 10.1159/000494442. Epub 2018 Oct 22.

31.

Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, Schunk SJ, Petrakis I, Schmit D, Wagenpfeil S, Heine GH, Mayer G, Floege J, Fliser D, Gröne HJ, Speer T.

J Am Soc Nephrol. 2018 Nov;29(11):2722-2733. doi: 10.1681/ASN.2018040405. Epub 2018 Oct 2.

32.

[What is certain in the treatment of glomerulonephritis?]

Floege J, Boor P, Moeller MJ.

Internist (Berl). 2018 Dec;59(12):1268-1278. doi: 10.1007/s00108-018-0500-8. Review. German.

PMID:
30250965
33.

Magnesium Concentration in Dialysate: Is Higher Better?

Floege J.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1309-1310. doi: 10.2215/CJN.08380718. Epub 2018 Aug 21. No abstract available.

34.

YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy.

Gibbert L, Hermert D, Wang J, M Breitkopf D, Alidousty C, Neusser M, Cohen CD, Gröne E, Macheleidt I, Rauen T, Braun GS, Floege J, Ostendorf T, Raffetseder U.

Clin Immunol. 2018 Sep;194:67-74. doi: 10.1016/j.clim.2018.07.002. Epub 2018 Jul 3.

PMID:
30018024
35.

Sucroferric oxyhydroxide for the treatment of hyperphosphatemia.

Sprague SM, Floege J.

Expert Opin Pharmacother. 2018 Jul;19(10):1137-1148. doi: 10.1080/14656566.2018.1491548. Epub 2018 Jul 9. Review.

PMID:
29985725
36.

IgA nephropathy: new insights into the role of complement.

Floege J, Daha MR.

Kidney Int. 2018 Jul;94(1):16-18. doi: 10.1016/j.kint.2018.03.009.

PMID:
29933843
37.

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.

Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V, Walpen S, Floege J.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1163-1170. doi: 10.1093/ndt/gfy127.

38.

[Screening: Let's Seize the Opportunity for Early Detection of Diseases].

Floege J.

Dtsch Med Wochenschr. 2018 Jun;143(11):761. doi: 10.1055/a-0594-5181. Epub 2018 May 28. German. No abstract available.

PMID:
29807372
39.

Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients.

Carrero JJ, Cabezas-Rodríguez I, Qureshi AR, Floege J, Ketteler M, London G, Locatelli F, Memmos D, Goldsmith D, Ferreira A, Nagy J, Teplan V, Martínez-Salgado C, Fernández-Martín JL, Zoccali C, Cannata-Andia JB; COSMOS group.

Nefrologia. 2018 Sep - Oct;38(5):520-527. doi: 10.1016/j.nefro.2018.02.009. Epub 2018 Jun 11. English, Spanish.

40.

Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study.

Fernández-Martín JL, Dusso A, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Górriz JL, Rutkowski B, Bos WJ, Tielemans C, Martin PY, Wüthrich RP, Pavlovic D, Benedik M, Rodríguez-Puyol D, Carrero JJ, Zoccali C, Cannata-Andía JB; COSMOS group.

Nephrol Dial Transplant. 2019 Apr 1;34(4):673-681. doi: 10.1093/ndt/gfy093.

PMID:
29741651
41.

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Marx N, Noels H, Jankowski J, Floege J, Fliser D, Böhm M.

Clin Res Cardiol. 2018 Aug;107(Suppl 2):120-126. doi: 10.1007/s00392-018-1260-0. Epub 2018 May 4. Review.

PMID:
29728829
42.

Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients.

Sprague SM, Ketteler M, Covic AC, Floege J, Rakov V, Walpen S, Rastogi A.

Hemodial Int. 2018 Oct;22(4):480-491. doi: 10.1111/hdi.12663. Epub 2018 Apr 15.

PMID:
29656600
43.

Inverse correlation between vascular endothelial growth factor back-filtration and capillary filtration pressures.

Kuppe C, Rohlfs W, Grepl M, Schulte K, Veron D, Elger M, Sanden SK, Saritas T, Andrae J, Betsholtz C, Trautwein C, Hausmann R, Quaggin S, Bachmann S, Kriz W, Tufro A, Floege J, Moeller MJ.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1514-1525. doi: 10.1093/ndt/gfy057.

44.

The new SFB/TRR219 Research Centre.

Noels H, Boor P, Goettsch C, Hohl M, Jahnen-Dechent W, Jankowski V, Kindermann I, Kramann R, Lehrke M, Linz D, Maack C, Niemeyer B, Roma LP, Schuett K, Speer T, Wagenpfeil S, Werner C, Zewinger S, Böhm M, Marx N, Floege J, Fliser D, Jankowski J.

Eur Heart J. 2018 Mar 21;39(12):975-977. doi: 10.1093/eurheartj/ehy083. No abstract available.

PMID:
29579229
45.

CTLA-4 Polymorphisms in Patients with IgA Nephropathy Correlate with Proteinuria.

Jacob M, Ohl K, Goodarzi T, Harendza S, Eggermann T, Fitzner C, Hilgers RD, Bolte A, Floege J, Rauen T, Tenbrock K.

Kidney Blood Press Res. 2018;43(2):360-366. doi: 10.1159/000488069. Epub 2018 Mar 8.

46.

Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial.

Floege J, Tsirtsonis K, Iles J, Drueke TB, Chertow GM, Parfrey P.

Kidney Int. 2018 Jun;93(6):1475-1482. doi: 10.1016/j.kint.2017.12.014. Epub 2018 Mar 7.

PMID:
29525393
47.

IgA nephropathy: toward more specific diagnosis (and rescue of snails).

Floege J.

Kidney Int. 2018 Mar;93(3):542-544. doi: 10.1016/j.kint.2017.10.028.

PMID:
29475546
48.

Prognostic value of cardiovascular calcifications in hemodialysis patients: a longitudinal study.

Dimkovic N, Schlieper G, Jankovic A, Djuric Z, Ketteler M, Damjanovic T, Djuric P, Marinkovic J, Radojcic Z, Markovic N, Floege J.

Int Urol Nephrol. 2018 May;50(5):939-946. doi: 10.1007/s11255-018-1821-1. Epub 2018 Feb 13.

PMID:
29441480
49.

[Internal Medicine - from Guidelines to "Choosing Wisely"].

Floege J.

Dtsch Med Wochenschr. 2017 Dec;142(24):1785. doi: 10.1055/s-0043-118227. Epub 2017 Dec 5. German. No abstract available.

PMID:
29207420
50.

Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.

Stamellou E, Floege J.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1683-1689. doi: 10.1093/ndt/gfx322. Review.

PMID:
29206932

Supplemental Content

Loading ...
Support Center